MIT CEO
June 17 - 18, 2025
Koch Institute at MIT
In order to further cultivate biomedical innovation and the advancement of medicines to help patients, Longwood Healthcare Leaders is gathering thought leaders across pharma, biotech, government, academia, healthcare, and investing for two days of discussion and networking. Join us June 17-18 for this not-to-be missed event at MIT’s Koch Institute.
Longwood Healthcare Leaders MIT CEO is co-hosted by
MIT President Sally Kornbluth, Institute Professors Bob Langer (NAS,
Co-Founder, Moderna), and Phil Sharp (Nobel laureate, Co-Founder, Biogen/Alnylam).
.jpg)
Featured Speakers
Policy and Provider Perspectives
Academic Leaders
BioPharma CEOs
Pharma R&D & Strategy Leaders
Venue
Longwood Healthcare Leaders MIT CEO
will be held at MIT’s Koch Institute
500 Main Street, Cambridge, MA
in Cambridge’s Kendall Square.
Agenda
7:00 am
REGISTRATION & NETWORKING BREAKFAST
7:30 am
LONGWOOD FUND INTRODUCTION
8:00 am
(BIG BIO)PHARMA PIPELINE SOURCING
Bob Bagdorf, Head, WWBD, Pfizer
Tarek Rabah, CEO, Otsuka North America
8:30 am
TRANSLATING SCIENCE INTO MEDICINE
Nello Mainolfi, CEO, Kymera Therapeutics
Brent Vaughan, CEO, Eratos Therapeutics
Moderator: Chen Schor, CEO, Adicet Bio
9:00 am
DRIVING PRODUCTIVITY IN R&D
Ryan Fukushima, CEO, Pathos AI
Lara Sullivan, CEO, Pyxis Oncology
Richard Wilson, SVP, Primary Focus Lead, Genetic Regulation, Astellas
Moderator: Harvey Berger, CEO, Kojin Therapeutics
9:30 am
REGULATORY & INDUSTRY ROUNDTABLE
Peter Marks, Director, CBER, FDA
10:00 am
NETWORKING BREAK
10:30 am
TARGETED LICENSING & ACQUISITIONS
Miguel Fernández Alcalde, President, EMD Serono
Ansbert Gadicke, Managing Partner, MPM BioImpact
Raju Prasad, CFO, CRISPR Therapeutics
11:00 am
PLATFORM TO PIPELINE
Greg Geba, SVP, Global Development, Regeneron
Dror Harats, CEO, ImmuneWalk Therapeutics
Peter Tummino, President, R&D, Nimbus Therapeutics
11:30 am
GUBERNATORIAL KEYNOTE
Maura Healey, Governor, Massachusetts
12:00 pm
NETWORKING LUNCHEON
1:00 pm
DEVELOPING AN EFFECTIVE BOARD
Jeff Cleland, CEO, Ashvattha Therapeutics
1:30 pm
NAVIGATING PARTNERSHIPS ACROSS BORDERS
Christian Behrenbruch, CEO, Telix Pharma
Konstantina Katcheves, SVP, Innovative Medicines BD, Teva
Ken Keller, CEO, Daiichi Sankyo, Inc.
Deniz Razon, CBO, Servier Pharmaceuticals
2:00 pm
CAPITAL MARKET PERSPECTIVES
Gaurav Shah, CEO, Rocket Pharma
Jason Fenton, Managing Director, Co-Head, ECM, Cantor
2:30 pm
NETWORKING BREAK
3:00 pm
NAVIGATING THE REGULATORY LANDSCAPE
Peter Hutt, former General Counsel, FDA
3:30 pm
INNOVATIVE COMMERCIAL MODELS
Robert Blum, CEO, Cytokinetics
Debbie Drane, SVP, Global Commercial Development & TA Strategy, CSL
Shalabh Gupta, CEO, Unicycive Therapeutics
Vikram Karnani, CEO, Collegium Pharmaceutical
4:00 pm
MAINTAINING PATIENT-CENTRIC FOCUS
Julie Kim, President, US, Takeda
Anne Klibanski, CEO, Mass General Brigham
4:30 pm
ASSESSING INVESTMENT RISK
Ketki Karanam, Partner, Translational Sciences, UPMC Enterprises
Søren Møller, Managing Partner, Novo Holdings
Tuesday, June 17
Wednesday, June 18
7:00 am
REGISTRATION & NETWORKING BREAKFAST
7:30 am
LONGWOOD FUND INTRODUCTION
8:00 am
IDENTIFYING NEXT-GENERATION THERAPEUTICS
Ashley Lakner, Head, Oncology Discovery, pRED, Roche
Zdravka Medarova, CSO, TransCode Therapeutics
Ameet Nathwani, CEO, Dewpoint Therapeutics
8:30 am
ADVANCEMENTS IN CLINICAL TRIALS
William Williams, CEO, BriaCell
8:50 am
SPOTLIGHT ON BIOMEDICAL INNOVATION
Todd Golub, Founding Core Member, Broad Institute
Susan Hockfield, President Emerita, MIT
9:20 am
FIRESIDE CHAT
Yvonne Greenstreet, CEO, Alnylam
9:40 am
NETWORKING BREAK
10:10 am
FIRESIDE CHAT
George Daley, Dean, Harvard Medical School
Sally Kornbluth, President, MIT
10:40 am
MANAGING THE RUNWAY
Nadim Ahmed, CEO, Cullinan Therapeutics
Robert Ryan, CEO, Innova Therapeutics
Devyn Smith, CEO, Arbor Bio
11:10 am
SUPPORTING RESEARCH AT THE INTERSECTION OF POLICY & SCIENCE
11:40 am
ACCELERATING DRUG DEVELOPMENT
Ben Liu, CEO, Formation Bio
Roger Tung, former CEO, Concert Pharmaceuticals
12:00 pm
NETWORKING LUNCHEON
1:00 pm
ADVANCING LATE STAGE ASSETS
Beth Shafer, CBO, Scholar Rock
Moderator: Teresa Bitetti, President, Global Oncology, Takeda
1:30 pm
ENSURING HEALTH EQUITY & ACCESS
Caroline Kant, CEO, EspeRare Foundation
Jeb Keiper, Vice Chair, Life Science Cares; former CEO, Nimbus Therapeutics
2:00 pm
FIRESIDE CHAT
Eliav Barr, CMO, Merck
2:20 pm
R&D COLLABORATION
Mace Rothenberg, former CMO, Pfizer
2:50 pm
ACCELERATING DRUG DISCOVERY
3:20 pm
NETWORKING BREAK
3:40 pm
FIRESIDE CHAT
Christophe Weber, CEO, Takeda
4:00 pm
ECOSYSTEM OF EXTERNAL INNOVATION
Jie D’Elia, CEO, SystImmune
Jennifer Michaelson, CSO, Cullinan Therapeutics
Zhen Su, CEO, Marengo Therapeutics
4:30 pm
INVESTMENT OUTLOOK
Mike Ehlers, Entrepreneur Partner, MPM BioImpact
5:00 – 6:30 pm
COCKTAIL RECEPTION
Speaking Faculty
